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Abstract
N-Myc downstream-regulated gene 2 (NDRG2) is a candidate tumor suppressor gene, which plays an important role
in controlling tumor growth. The aim of this study was to investigate the expression of NDRG2 gene in bladder cancer
(BC) tissues and several bladder cancer cell lines, and to seek its clinical and pathological significance. Ninety-seven
bladder carcinoma and 15 normal bladder tissue sections were analyzed retrospectively with immunohistochemistry.
The human bladder cancer cell line T24 was infected with LEN-NDRG2 or LEN-LacZ. The effects of NDRG2
overexpression on T24 cells and T24 nude mouse xenografts were measured via cell growth curves, tumor growth
curves, flow cytometric analysis, western blot and Transwell assay. NDRG2 was highly expressed in normal bladder
tissue, but absent or rarely expressed in cacinomatous tissues (χ2=8.761, p < 0.01). The NDRG2 level was
negatively correlated with tumor grade and pathologic stage(r=-0.248, p < 0.05), as well as increased c-myc level
(r=-0.454, p< 0.001). The expression of NDRG2 was low in the three BC cell lines. T24 cells infected with LEN-
NDRG2 showed inhibition of proliferation both in vitro and in vivo, and NDRG2 overexpression can inhibit tumor
growth and invasion in vitro.
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Introduction
The incidence of bladder cancer is increasing. An estimated
386,300 new cases and 150,200 deaths from bladder cancer
occurred in 2008 worldwide [1]. In men, bladder cancer is the
fourth most common cancer only after prostate, lung, and
colorectal cancers, accounting for 7% of all cancer cases in
USA [2]. In more than 75% of the cases, the diagnosis is made
at an early stage of disease (stages Ta and T1). Despite
having received adequate treatment, the five-year overall
survival rate for pathologic T2 disease is 52–77%, T3 disease
40–64%, and T4 or lymph node-positive disease 26–44% [3].
There are numeral therapeutic interventions to treat this
disease; however, the overall survival rate has not been
improved in the last twenty years. Therefore, to establish a new
mode of therapy using antioncogene agent to improve the
survival rate of patients is highly desirable.
The N-myc downstream regulate gene 2 (NDRG2) belongs
to the NDRG family, which includes four members: NDRG1,
NDRG2, NDRG3 and NDRG4. The sequence homology within
the human NDRG family is 57-65% and the NDRG family has
been investigated in some of human cancer and nervous
system disorders [4]. As a gene to regulate downstream of
Myc, NDRG2 expression has been confirmed to be reduced in
many types of carcinomas, including thyroid cancer, liver
cancer, meningioma, pancreatic cancer and prostate cancer
[5–11]. These studies suggest that NDRG2 might play an
important role in controlling morbidity of carcinomas. The
NDRG2 has been confirmed to be involved in cell growth and
differentiation, meanwhile, NDRG2 expression in high-grade
gliomas has been shown to associate with survival [12,13].
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Though several studies have investigated the function of
NDRG2 in common tumors, there has not been functional
characterization of the potential role of NDRG2 gene in bladder
cancer. Therefore, the aim of the current study was to
investigate the role of NDRG2 in human bladder cancer. First,
we examined the expression of NDRG2 in human bladder
carcinoma tissues and compared to normal bladder tissues by
immunochemistry. We found that the expression level of
NDRG2 in BC tissues was lower than that in normal tissues.
Next, we used bladder cancer cell lines as models to evaluate
the effect of NDRG2 on tumor growth, differentiation and
invasion in vitro and in vivo. Our results suggest that NDRG2
has a potential antioncogenic role in bladder cancer.
Materials and Methods
Clinical Samples
Formalin-fixed and paraffin-embedded blocks of bladder
carcinoma tissues were randomly collected from 112 patients
and controls (mean age 63.4 years, range from 21 to 81 years)
from the Department of Urologic Surgery, Xijing Hospital,
FMMU (Xi’an, China) between 2008 and 2011.These samples
comprised 15 normal bladder tissues, 20 bladder papilloma
(T0-Ta), 38 low-level bladder cancer(Tis-T1) and 39 high-level
bladder cancer samples(T2-T4). Written consent was obtained
from each subject. This study was approved by the Ethics
Committee of Xijing Hospital, Xi’an, China.
Immunohistochemistry (S-P: streptavidin-perosidase)
Mouse anti-human NDRG2 monoclonal antibody and c-Myc
monoclonal antibody were purchased from Santa Cruz
Biotechnology Company (Santa Cruz, USA.). The
immunohistochemistry kit was purchased from the Boster
Company (Wuhan, China). The immunohistochemistry staining
was performed according to the manufacturer’s instruction. The
following preparations were made from each tissue block: a
slide stained with HE (the pathologic stage were checked by
pathologists), a slide incubated with anti-NDRG2 antibody, a
slide incubated with c-myc antibody.
In order to accurately determine the positive expression and
to minimize the false-positive rate, we used two arbitory semi-
quantitative scoring system to evaluate the extent and intensity
of the staining by three pathologists independently. The scores
were defined as follows: (1) the extent of staining scoring: 0
Figure 1.  The expression of NDRG2 and c-Myc protein in bladder carcinoma tissues detected with immunohistochemistry
staining.  (A) The expression levels of NDRG2 protein decrease while the degree of malignancy of bladder carcinoma increases
(x400)(1). Normal bladder tissue; (2) Bladder papilloma(T0-Ta); (3) High-level bladder cancer(T2-T4). (B) The expression levels of
c-Myc protein increases while the degree of malignancy of bladder carcinoma increases (x400)(4). Normal bladder tissue; (5)
Bladder papilloma(T0-Ta); (6) High-level bladder cancer(T2-T4). The sections of (B) (4–6) originated from the same paraffin blocks
as (A) (1–3) respectively.
doi: 10.1371/journal.pone.0076689.g001
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point for staining <5%, 1 point for staining 6% to 25%, 2 point
for staining 26% to 50%, 3 point for staining 51% to 75%, and 4
point for staining > 75%(2). The intensity of staining scoring: 0
point for negative staining, 1 point for weakly positive staining,
2 points for moderate staining and 3 points for strong staining
(tan). For each specimen, the scores derived from the two
scoring systems were multiplied. The results of determination
were divided into four levels: negative (0 to 1, -), weakly
positive (2 to 4, +), positive (5 to 8, + +), strong positive (9 to
12, + + +). Imaging was performed by light microscopy
(Olympus, Nagano, Japan) and calculated with statistical
analysis.
Cell Culture
We selected human T24, 5637 and BIU-87 cells lines to be
used in the current investigation. These cell lines have been
previously confirmed as the appropriate cell lines for the
research of bladder cancer. As normal control, we chose
human bladder cell (SV-HUC-1). All the cell lines were
purchased from the Cell Bank, Chinese Academy of Sciences,
Shanghai, China. The cells were cultured in RPMI1640 (Gibco)
supplemented with 10% fetal bovine serum (Sijiqing Hangzhou,
China). All the cell lines were cultured in sterile conditions at
37°C and 5% CO2.
Real-time Quantitative PCR
The total RNA was extracted from cells using TRIzol reagent
(Takara Bio, Japan) and reverse transcribed using M-MLV
Reverse Transcriptase (Fermentas) according to the
manufacturer’s instruction. The primers used were as follows:
GAPDH, 5′-AGGTCCACCACTGACACGTT-3′ and 5′-
GCCTCAAGATCATCAGCAAT-3′; NDRG2, 5′-
GCCCAGCGATCCTTACCTACC-3′ and 5′-
GGCTGCCCAATCCATCCAACC-3′. The amplification program
consisted of polymerase activation at 95°C for 30 seconds and
40 cycles of denaturation at 95°C for 15 seconds, annealing
and extension at 59°C for 30 seconds. The relative expression
levels were normalized using the comparative threshold cycle
(2 -∆∆Ct). The Real-time PCR performed by using CFX96 Touch
PCR system (Bio-Rad). All above mentioned experiments were
repeated at least three times.
Western Blotting Analysis
All the cells were collected in exponential phase and then the
total protein was extracted with lysis buffer containing 1%
Tween 20, and finally quantitated with BCA assay. Equal
amount of proteins 20µg were subjected to 10% concentration
SDS-PAGE. The proteins separated by SDS-PAGE within the
gels were transferred onto nitrocellulose (NC) membranes
(Amersham, St. Giles, UK). Subsequently, the NC membranes
were blocked with 5% non-fat milk for 1h at room temperature
and then incubated with mouse anti-human NDRG2 antibody
(1:800) (Santa Cruz, USA) overnight at 4°C. GAPDH protein
detection was used as an internal control. After washing three
times, the transferred blots containing NDRG2 bands were
visualized with horseradish-peroxidase (HRP)-conjugated anti-
mouse or anti-rabbit secondary antibody (dilution 1: 2000,
Santa Cruz) for 2 h at room temperature. The enhanced
chemiluminescence (ECL) system detection solutions (Pierce,
NJ) were then applied, and quantified by Kodak Digital Science
ID software (Kodak, NY).
Lentivirus Infection
To produce lentivirus, 293T cells were co-transfected with
pLEN-GFP-NDRG2 or pLEN-GFP-Lacz, which were amplified
in E. coli DH5, purified using a Plasmid Maxi Kit (Qiagen,
Figure 2.  Differential expression of NDRG2 among bladder cancer cell lines.  (A) Real-time PCR analysis of NDRG2 mRNA
expression. (B) Expression level of NDRG2 protein as assayed by western blot. All the assays were repeated independently for at
least three times. The results are shown as the mean ± SD (** p<0.001)..
doi: 10.1371/journal.pone.0076689.g002
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Valencia, CA), and transfected into 70% confluent 293T cells
using lipofectamine 2000 (Invitrogen). Lentiviral particles were
harvested from the supernatant 72 hours after transfection and
purified by ultracentrifugation. These particles were hereafter
referred to as LEN-NDRG2, and LEN-Lacz (negative control).
Stably infected T24 cells were selected using blasticidin, by
counting green fluorescent protein (GFP)-positive cells under
fluorescence microscopy (Olympus, Japan), applied at the
minimum concentration of blasticidin, after a serial titration,
required to kill uninfected T24 cells. The cell line was divided
into the following three experimental groups: 1) NDRG2 group
(LEN-NDRG2-infected cells), 2) Lacz group (LEN-Lacz-infected
cells), and 3) CON group (non-infected cells). Both Real-time
PCR and Western blot confirmed that we successfully infected
T24 cells with the lentiviral and overexpression of NDRG2
properly after infection. We also ascertained the differential
expression of proteins that correlated with cell cycle stage,
apoptosis and cell migration and invasion (cell cycle protein:
cyclinD1, CDK4; cell apoptosis protein: p21; cell migration and
invasion protein: MMP-2 and MMP-9).
Cell Growth Inhibition Tests in Vitro
This test included MTT assays, Colony formation assays and
flow cytometric analysis (FCA) (BD Biosciences, NJ). Each
assay was applied to each of the three groups (the blank
control; LEN-LacZ, the negative control; and LEN-NDRG2, the
experimental group). The experiments were repeated five
times(1). MTT assay: All the cells, including those infected,
were grown in exponential phase and detached by trypsin
treatment. Viable cells (2000 cells/ml) were inoculated into 96-
well plates and every group had six reduplicative wells. At
different time points, MTT reagent was added 20 μl/well
(5mg/ml) and incubated at 37 °C for 4 h. The reaction was
stopped by the addition of 150 µl dimethyl sulfoxide (DMSO)
followed by shaking for 10 min. Absorbance (A) values were
measured with an autokinetic enzyme scaling meter (Bio-Rad,
USA) at 490 nm wavelength. Cell growth curves then were
Figure 3.  pLEN-GFP-NDRG2 infected T24 cells to increased NDRG2 expression in bladder cancer cells.  (A) Detection of
lentiviral infection efficiency, and phase contrast (left) or GFP (right) images were obtained four days after infection. (B) Real-time
PCR analysis of NDRG2 mRNA expression in T24 cells. (C) Western blot analysis of NDRG2 protein expression. The results are
shown as the mean ± SD (** p<0.01)..
doi: 10.1371/journal.pone.0076689.g003
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then drawn based on the average A values(2). Colony
formation assay: Cells were seeded into six -well plates (200
cells /well) (in three duplicate wells) and cultured at 37°C in 5%
CO2. After two weeks, the cells were fixed with methanol for 20
min and then stained with Giemsa for 20 min. ddH2O was used
to wash the cells three times to obtain a clean background. The
number of colonies and the cell number in each colony were
counted and statistically analyzed(3). FCA: T24 cells (1 x 106
cells/ well) were plated in six-well culture dishes with lentivirus
infected LEN-NDRG2. Three groups of cells were collected
after 48h and 72h respectively and finally centrifuged and fixed
in 95% ethanol. After overnight incubation at 4°C, cells were
stained with 0.5% propidiumiodide (10µl) in the presence of
0.01% RNAse A and 0.1% Triton X-100, then were measured
with a flow cytometer.
Migration and Invasion Assays
Invasion assay with a Matrigel-coated membrane and
migration assay with no Matrigel membrane were performed
using a 24-well Transwell inserts (8µm pore filters, BD
Biosciences, Bedford, MA), which were performed according to
manufacturer’s instructions. The exponential phase cells were
harvested and resuspended (2×105 cells/ml) in serum-free
medium, then seeded and resuspended in 200µl culture
medium in the upper chamber. Next, culture medium with 20%
FBS was placed in the bottom well. The Transwell were
incubated at 37°C and 5% CO2 atmosphere over night. The
T24 cells were allowed to migrate through a porous to the
bottom of the membrane. After incubation, the cells on the
bottom of the membrane were fixed with methanol for 5 min
and then stained with Kristallviolet. The number of invading
Figure 4.  NDRG2 overexpression inhibits proliferation of human bladder cancer cells.  (A and B) Colony formation assay.
Upregulation of NDRG2 inhibits colony formation. (C) The cell growth curves of T24 cells by MTT method. All the assays were
repeated independently for at least three times. The results are shown as the mean ± SD (*=p<0.001).
doi: 10.1371/journal.pone.0076689.g004
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cells or migrating cells was determined by microscope at a
400x magnification on each membrane and calculated the
mean number of cells per field. All the assays were repeated at
least three times independently.
Growth Inhibition Assays in Vivo
Six-week-old male BALB/c nude mice were purchased from
Shanghai Experimental Animal Center, Shanghai, China. The
LEN-NDRG2 group and LEN-Lacz group cells were harvested
and resuspended with 1 × PBS and the concentration was
adjusted to 5 × 107 per ml, 200µl cell solution (1 x 107 cells)
were injected subcutaneously into the left flanks of the nude
mice. The mice were randomly divided into two groups: LEN-
NDRG2 and LEN-LacZ (n=5 per group). When the mean size
of inoculated tumors reached to 300 mm3 (as calculated by the
equation: V [mm3] = ab2 /2) in vivo, the mice were sacrificed by
cervical dislocation and tumor specimens were collected,
photographed and measured for their volumes and weight. The
mice were anatomized to check whether there were metastasis
to other organ and lymph node. The expression of NDRG2
protein in the inoculated tumors of nude mice was detected by
western blot. Other markers for protein expression were also
measured, including cell cycle protein: cyclinD1, CDK4; cell
apoptosis protein: p21; cell migration and invasion protein:
MMP-2, MMP-9.
Statistical Analysis
Statistical analyses were performed using SPSS17.0
software (SPSS company, IN). All data are represented as the
mean ± standard error derived from at least three independent
experiments. For immunohistochemistry, differences across
groups were validated using Chi-square tests and Pearson
correlation. Analysis of variance (ANOVA), Student-Newman-
Keuls (SNK) tests and non-parametric test were performed to
determine whether there were differences among the results of
assays in vitro and in vivo assays. A P-value less than 0.05
were considered statistically significant.
Results
The frequency of positive expression of NDRG2 in bladder
carcinoma tissues was 39.17% (38/97), which was lower than
that in normal bladder tissues (80%, 12/15), (χ2= 8.761,
P<0.01) (Table 1). NDRG2 expression, both frequency and
levels, was not correlated with gender or age, but was inversely
correlated with pathologic stage (r=-0.248, P<0.05) (Table 2).
Immunohistochemistry showed that NDRG2 protein positive
was staining in the cytoplasm of normal tissues and bladder
carcinoma (Figure 1A). The expression levels of NDRG2 in
bladder carcinoma were inversely correlated with c-Myc in
bladder carcinoma (r=-0.454, P<0.001) (Figure 1B).
Both western blot and Real-time PCR showed that all three
BC cell lines had lower expression levels of NDRG2 protein
and mRNA than the normal human bladder cells (SV-HUC-1).
Among the three BC cell lines, the T24 cells showed the lowest
expression levels(Figure 2A, B).
It was shown by fluorescence microscopy that the efficiency
of infection was high being more than 95% (Figure 3A). Real-
time PCR analysis showed that the mRNA expression levels of
NDRG2 in the LEN-NDRG2 group was significantly higher than
that in the LEN-Lacz(negative group) and CON groups
(P<0.05) (Figure 3B). Western blot analysis showed that the
NDRG2 protein level in the LEN-NDRG2 group was higher
than that in the LEN-Lacz and CON groups (Figure 3C). The
LEN-NDRG2 also caused overexpression of NDRG2 in T24
cells. The cell growth curves and colony formation showed that
overexpression of NDRG2 could suppress the growth of T24
cells more than that of in the other two groups. In the cell
growth curves assays, the inhibition began at the third day and
became more obviously thereafter (F≥44.58, P< 0.01) (Figure
4). The FCA showed that the T24 cells with LEN-NDRG2 could
increase the proportion of cells in G0 /G1 compared to the LEN-
LacZ groups and negative control, indicating that the
ovexpression of NDRG2 had made the T24 cells to arrest in G1
cycle (48 h: F = 41.92, P < 0.01; 72 h: F = 24.11, P < 0.01).
(Figure 5, Table 3.) The western blot showed that
overexpression of NDRG2 downregulated CDK4 and cyclinD1,
while upregulate p21 in T24 cells (Figure 6a, b).
Transwell migration assays and Matrigel-coated transwell
invasion assays were performed with T24 cells. The
representative micrographs were taken from the lower surface
of the transwell filter, and cells which migrated or invaded were
stained with Kristallviolet. As shown in Figure 7A, the invasive
potential, which is determined by the cells’ ability to invade a
Matrigel barrier, was also considerably suppressed in NDRG2-
overexpressing cells (P <0.01). Furthermore, forced expression
of NDRG2 in T24 cells significantly suppressed their migration
through the transwell (P < 0.01) (Figure 7B).
In western blot assays, compared with the LEN-Lacz group
and blank controls, the group of LEN-NDRG2 can suppress
MMP-2, MMP-9 protein expression level in T24 cell (Figure 7C,
D). MMP-2 and MMP-9 were highly expressed in bladder
cancer metastasis, so the NDRG2 likely inhibited the
metastasis of bladder cancer by regulating the expression of
MMP-2 and MMP-9.
The tumor growth curves was drawn by measuring the size
of tumors. All the nude mice survived after injections with
lentivirus. The T24 cells were injected 2 weeks later, the
tumor’s volume of two groups began to appear differently.
From three weeks, the difference in tumor volume started to
show statistical significant (F≥31.65, p<0.001) (Figure 8B).
Compared with the LEN-Lacz group, the tumor’s weight by
LEN-NDRG2 was significantly lighter (F≥39.82, p<0.001)
(Figure 8D). The ratio of tumor weight to mouse weight
indicated that the physical condition of the mice in LEN-NDRG2
group was much better than that of the mice in LEN-LacZ
group (F = 39.81, p < 0.001) (Figure 8C), indicating that the
overexpression of NDRG2 could suppress the growth of
tumors. Upon anatomizing the mice, ipsilateral lymph node
metastases were shown in the LEN-LacZ group, but no other
organs were involved; however, in the LEN-NDRG2 group no
any metastatic lesion was found (Figure 8A). Western blot
showed that the NDRG2 protein was upregulated in the tumors
of LEN-NDRG2 group, and that overexpression of NDRG2
downregulated cyclinD1, CDK4, MMP-2, MMP-9; and
upregulated p21 in vivo(Figure 9A, B).
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Figure 5.  FCA of cell cycle arrest and apoptosis induced by overexpression of NDRG2.  (A) T24cells infected with LEN-
NDRG2 lentivirus were more obviously arrested in G0/G1cycle. (B) Percentages of apoptotic cells in LEN-NDRG2 groups were
greater than in the other two groups(1–3). 48 h after the infection (4–6); 72 h after the infection; (1 and 4) blank control (PBS); (2
and 5) LEN-LacZ; (3 and 6) LEN-NDRG2. All the assays were repeated independently for at least three times. The results are
shown as the mean ± SD.
doi: 10.1371/journal.pone.0076689.g005
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Discussion
Approximately 75% of all bladder cancer patients recur within
the first 5 years [14], this high rate of recurrence of bladder
cancer and its significant metastatic potential have made
patients’ care and prognosis challengeable. Therefore, to
increase early diagnosis rate and also to establish novel
therapeutic approaches are urgently needed through research
of bladder cancer. NDRG2 is a candidate tumor suppressor
gene, and a series of studies have confirmed that it plays an
important role in cell proliferation, apoptosis and metastasis
[15,16]. Our results in the current study obtained from bladder
cancer support these early findings.
We demonstrated that NDRG2 plays an important role in
bladder cancer that is similar to its role in other malignant
tumors. Immunohistochemistry results showed that the positive
expression level of NDRG2 in bladder carcinoma tissues was
significantly lower than that in normal bladder tissues. The
expression levels of NDRG2 decreased as the degree of
bladder carcinoma malignancy increased. We also found that
the expression of NDRG2 was inversely correlated with c-Myc,
similar to that seen in other tumor cells. Meanwhile, the
NDRG2 expression levels in bladder cancer cell lines (T24,
5637 and BIU-87) were lower than normal bladder cell line (SV-
HUC-1).
Lentiviruses have been shown to be suitable for gene
therapy, because they can steady integrate into the host
genome to provide long term expression of target gene, in
addition, lentiviruses have been confirmed to be progressively
safe by the development of split plasmid systems for vector
production to prevent generation of replication-competent virus
[17].
Table 1. The Expression of NDRG2 in normal bladder tissue and bladder carcinoma tissues.
Group NDRG2(-) NDRG2(+) X2value p value
Normal tissue 3 12   
Bladder carcinoma 59 38 8.761 <0.01
Data are presented as n (number of samples). Statistical significance was evaluated with χ2test.
doi: 10.1371/journal.pone.0076689.t001
Figure 6.  The influences of NDRG2 overexpression on T24 cells infected with lentivirus.  (A) The effect of NDRG2
overexpression on G1 cell cycle and apoptosis regulators as assayed by western blot. (B) Relative quantification of protein
expression, normalized to GAPDH levels. The figure shows the tendency of each group as indicated. All the assays were repeated
independently for at least three times. The results are shown as the mean ± SD (** p<0.01)..
doi: 10.1371/journal.pone.0076689.g006
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Investigations carried out by Liu et al. indicated that NDRG2
was a new target gene that is regulated by p53 and NDRG2
mRNA and protein levels can be up-regulated in a p53-
dependent manner. And they further reported that silencing of
NDRG2 attenuates p53-mediated apoptosis [18]. Meanwhile, it
was reported that NDRG2 could up-regulate the expression of
p53 in breast cancer cells [19]. These data strongly suggested
that NDRG2 was an important factor in regulating tumor cell
apoptosis. Meanwhile, the CDC20 was regulated by p53 to
inhibit the malignant cancer cells grow [20]. Cyclin D1 plays an
important role in the cell cycle, binds to cyclin-dependent
kinases (CDK4/6), and promotes phosphorylation of RB1,
orchestrating progression through the G1 restriction point [21].
NDRG2 may regulate the expression of proteins (p21, cyclinD1
and CDK4) in bladder cancer cells through up-regulation of
p53. We used lentivirus-mediated NDRG2 overexpression
strategy to inhibit the proliferation of T24 cells, to promote their
apoptosis both in vitro and in vivo; this mechanism has been
demostracted by regulating the expression of proteins p21,
cyclinD1 and CDK4, which are important in cell apoptosis and
cycle.
Recently, several reports suggest that NDRG2 might play a
vital role in inhibition of tumor metastasis. It is reported that
NDRG2 could antagonize transforming growth factorβ1-
mediated tumor cell invasion by specifically down-regulating
the expression of matrix metalloproteinase 2 and laminin 332
pathway components, with concomitant suppression of Rho
GTPase activity in hepatocellular carcinomas [22]. The MMP-2
and MMP-9 were high expression in muscle-invasive bladder
cancer and metastatic bladder cancer [21,23]. In this study,
western blot assay showed that LEN-NDRG2 in T24 cells was
associated with significant reduction in MMP-9 expression and
slightly reduced MMP-2 expression suggesting that NDRG2-
overexpression may regulate the expression of MMP-2 and
MMP-9 and inhibit the invasion ability of metastatic bladder
cancer cells. This conclusion was supported by both in vivo
and in vitro assays. We suspected that the expression of
NDRG2 significantly suppresses the MMP-2 and MMP-9 by
regulating the NF-kB signaling in the bladder cancer cells [24].
In conclusion, we have demonstrated the antioncogenic role
of NDRG2 in the development and invasion of bladder cancer.
Since NDRG2 is implicated in many aspects of tumor
progression, including cell growth, cell cycle regulation,
invasion and migration, it represents a promising therapeutic
target for bladder cancer. However, more investigations are still
needed to elucidate further the mechanism of NDRG2.
Research in this direction will finally provide new methods for
early diagnosis, novel therapy and postoperative monitor in
bladder cancer.
Table 2. The Relationship between the expression of NDRG2 and bladder carcinoma characteristics.
Clinicopathological Expression level of NDRG2 r-value p-value
Features − + ++ +++   
Gender
 Male 40 11 7 3   
 Female 19 12 5 0 0.32 0.759
Age
 ≤60years 23 10 6 1   
 >60years 36 13 6 2 -0.049 0.637
Grade
 Papilloma 10 4 4 2   
 Low 22 9 6 1   
 High 27 10 2 0 -0.248 0.014
Data are presented as n (number of samples). Statistical significance was evaluated with Pearson correlation coefficient test.
doi: 10.1371/journal.pone.0076689.t002
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Figure 7.  Overexpression of NDRG2 suppresses human bladder cancer cell invasion, migration and expression of MMP-2
and MMP-9.  (A) Invasion analysis of T24 cells treated with LEN-NDRG2. The invasion ability was estimated using Transwell
coated with Matrigel. The invasiveness of LEN-NDRG2 group cells was significantly lower than that in the other two groups.
**p<0.001. (B) Migration analysis of T24 cells treated with LEN-NDRG2. The migration ability was estimated using Transwell
uncoated with Matrigel. The migration ability of LEN-NDRG2 group cells was significantly lower than that in the other two groups.
**p<0.001. (C and D) Expression of MMP-2 and MMP-9 were measured after T24 cells were infected with LEN-NDRG2. LEN-
NDRG2 group reduced MMP-2 and MMP-9 expression compared to the other groups (** p<0.01).
doi: 10.1371/journal.pone.0076689.g007
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Table 3. The proportion of Cell cycle phase and cell apoptosis induced by LEN-NDRG2 on T24 cells.
Group  G0/G1 G2/M S Apoptosis
Control 48h 62.42±2.05 3.55±0.55 34.03±1.65 5.53±0.62
 72h 69.84±2.60 2.79±0.44 27.73±0.90 5.57±0.59
LEN-LacZ 48h 48h 64.24±1.92 3.56±0.56 32.21±0.66 6.49±1.25
 72h 69.63±2.40 3.08±0.40 27.29±0.61 6.52±1.17
LEN-NDRG2 48h 48h 71.40±0.37 8.50±0.47 20.10±0.30 10.25±2.43
 72h 77.61±0.99 7.05±0.15 15.34±0.17 12.88±3.01
Data are presented as % (Mean ± SD, n = 5). Statistical significance was evaluated with ANOVA and SNK tests. *P < 0.01, compared with the controls.
doi: 10.1371/journal.pone.0076689.t003
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Figure 8.  LEN-NDRG2 can suppress the growth of T24 xenografts in vivo.  (A) LEN-NDRG2 suppressed the growth of tumors
compared to LEN-LacZ. In addition to unsuppressed tumor growth, the LEN-LacZ group was found to have lymph node metastases.
(B) Tumor growth curves. (C) Ratios of tumor masses to mouse masses in different groups. (D) Masses of tumors in two groups.
The curves and histograms were drawn based on the average values (n = 5) in two groups. The results are shown as the mean ±
SD (*, ** p<0.001).
doi: 10.1371/journal.pone.0076689.g008
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Figure 9.  The influences of NDRG2 overexpression on T24 cells infected with lentivirus in vivo.  (A) The effect of NDRG2
overexpression on cell cycle, apoptosis and metastasis regulators as assayed by western blot. (B) Relative quantification of protein
expression, normalized to GAPDH levels. Western blots were analyzed with Kodak Digital Science one-dimensional software. The
figure shows the tendency of each group as indicated. All the assays were repeated independently for at least three times. The
results are shown as the mean ± SD (* p<0.01).
doi: 10.1371/journal.pone.0076689.g009
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